Open original FDA record ↗Recall record
- FDA identifier
- Z-2162-2025
- Company in FDA record
- Becton Dickinson & Co.
- FDA classification date
- Jul 23, 2025
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
Potential for functionality issue that supports the Over labeling feature and could lead to possible false negative results.
Source facts
- Action
- Becton, Dickinson and Company began notification of consignees on about 06/23/2025 via telephone call and followed by a letter. Consignees were instructed to note the outlined workflows when loading specimens with the Over labeling feature enabled and consider retesting affected specimens for HPV testing if affected. Consignees were also instructed to post the notification within their facility, notify customers if affected units were further distributed, and complete and return the provided Customer Response Form.
- Initiated
- 2025-06-23
- Root cause
- Under Investigation by firm
- Distribution
- Worldwide - US Nationwide distribution in the states of Florida, Texas and Michigan. The countries of Sweden and Belgium.
- Recall number
- Z-2162-2025
- Recall status
- Open, Classified
- CDRH record ID
- 214649
- FDA classified
- 2025-07-23
- Recall event number
- 97142